Radiologically identified tumor habitats

Patent metadata

Field	Value
Publication number	US-10827945-B2
Application number	US-201515124718-A
Country	US
Kind code	B2
Filing date	Mar 10, 2015
Priority date	Mar 10, 2014
Publication date	Nov 10, 2020
Grant date	Nov 10, 2020

Abstract

Virtually every cancer patient is imaged with CT, PET or MRI. Importantly, such imaging reveals that tumors are complex and heterogeneous, often containing multiple habitats within them. Disclosed herein are methods for analyzing these images to infer cellular and molecular structure in each of these habitats. The methods can involve spatially superimposing two or more radiological images of the tumor sufficient to define regional habitat variations in two or more ecological dynamics in the tumor, and comparing the habitat variations to one or more controls to predict the severity of the tumor.

First claim

What is claimed is:

1. A radiological method for predicting the severity of a tumor in a subject, comprising
(a) spatially superimposing two or more radiological images obtained by a magnetic resonance imaging (MRI) sequence thereby creating a spatial map of the tumor sufficient to define regional habitat variations in at least perfusion (blood flow) and interstitial cell density (edema) in the tumor, wherein the MRI sequence comprises i) defining perfusion variations using longitudinal relaxation time (T1)-weighted images and ii) defining interstitial cell density (edema) using transverse relaxation time (T2)-weighted images or fluid attenuated inversion recovery (FLAIR); and
(b) comparing the habitat variations from the spatial map of the tumor in the subject to one or more controls to predict the severity of the tumor.

2. The method of claim 1 , wherein the tumor is a glioblastoma multiforme (GBM).

3. The method of claim 1 , wherein the tumor is prostate cancer.

4. The method of claim 1 , wherein the tumor is a soft tissue sarcoma.

5. The method of claim 1 , wherein the tumor is a pancreatic cancer.

6. The method of claim 1 , further comprising defining regional habitat variations by extracellular pH (pHe).

7. The method of claim 1 , further comprising defining regional habitat variations by hypoxia.

8. The method of claim 1 , wherein the MRI sequence further comprises short tau inversion recovery (STIR).

9. The method of claim 1 , wherein the regional habitat variations are defined using a fuzzy clustering algorithm analysis of the radiological images.

10. The method of claim 1 , wherein the regional habitat variations are defined using a thresholding algorithm analysis of the radiological images.

11. The method of claim 1 , wherein the method predicts the survival of the subject based on the severity of the tumor.

12. The method of claim 1 , wherein detection of relatively low heterogeneity in regional habitats is an indication of low severity of the tumor.

13. The method of claim 1 , wherein detection of relatively high heterogeneity in regional habitats is an indication of high severity of the tumor.

14. The method of claim 1 , wherein detection of relatively high cell density and relatively high perfusion in the tumor is an indication of low severity of the tumor.

Assignees

• H Lee Moffitt Cancer Ct & Res
• Univ South Florida

Inventors

• Gillies Robert J
• Gatenby Robert A
• Raghunand Natarajan
• Arrington John
• Stringfield Olya
• Balagurunathan Yoganand
• Goldgof Dmitry B
• Hall Lawrence O

Classifications

• A61B5/055 Primary

  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging · CPC title

• A61B6/5247

  combining images from an ionising-radiation diagnostic technique and a non-ionising radiation diagnostic technique, e.g. X-ray and ultrasound · CPC title

• G01R33/56341

  Diffusion imaging · CPC title

• G01R33/5601

  involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent · CPC title

• A61B5/14539

  for measuring pH · CPC title